Company Information

Get to know Chardan Healthcare Acquisition 2 Corp

Chardan Healthcare Acquisition 2 Corp. was a blank check company, sponsored by an affiliate of Chardan Capital Markets LLC, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. The company raised approximately $115 million in its initial public offering in October 2020, with a stated focus on identifying a target in the healthcare industry, including the biotechnology, medical technology, and healthcare services sectors. In September 2021, the company successfully completed its business combination with Renovacor, Inc., a preclinical-stage gene therapy company.

Industry

Financial FundraisingPRIMARY
Financial Other Service

Contact

Social

Company hasn't updated its information.

THIS SERVICE IS NOT AVAILABLE IN YOUR REGION

Chardan Healthcare Acquisition 2 Corp

United States

Founded in

2020 (6 Years)

Founded

Last online: No recent activity

Claim company

TrustScore unavailableNot enough score to display the trend.

Be the first to rate and review this company.

OVERALL SCORE

Others

--/10

Reviews

--/90

0 reviews

Provided by TrustFinance

TrustScore unavailableNot enough score to display the trend.

Be the first to rate and review this company.

TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.

Regulated

Recommended

(74 reviews)

Cyprus

2009

(17 years)

Security Information :

CySEC

FSCA

DFSA

Security Information

Warning

This company is currently Unproved.

Please be cautious of the potential risks!

License

A Grade License

Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.

B Grade License

Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.

C Grade License

Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.

D Grade License

From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.

TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.